Despite market pressures, QinetiQ Group PLC (QNTQF) secures significant contracts and maintains a robust pipeline for future ...

Announced Encouraging Data on both NUC-7738 and NUC-3373 Initial Data from the Expansion Study of NUC-7738 Expected in Q4 2025 with Final Data Expected in 2026 Compliant with All Nasdaq Continued ...

Earnings call 3i Group reported a 13% total return for the half-year, with NAV per share rising to £28.57, up from £22.61 YoY. Private equity delivered a 14% gross investment return, led by Action’s ...

Entered into broad strategic collaboration with Eli Lilly and Company ('Lilly”) in the area of ophthalmology, granting Lilly worldwide exclusive rights to the Company’s AAV-AIPL1 program for treatment ...

Company reports Q3 2025 AUCATZYL® net product revenue of $21.1 million and deferred revenue of $7.6 million; 60 authorized treatment centers ...

Nanoform Finland Plc | Company Release | November 12, 2025 at 08:10:00 EET Our product kernels see good momentum. Nanoenzalutamide progresses with the fed arm of the pivotal human study. Licensing and ...

Single ascending dose data readout for VTP-1000 expected before the end of 2025Enrollment advancing in multiple ascending dose part of the AVALON ...

A conference call to discuss the Company's Q3 2025 operational and financial results will be held on Friday, November 7, 2025, at 8:00 a.m. PT / 11:00 a.m. ET. To participate in the conference call or ...

Net Income Attributed to Kopin Corporation for the third quarter of 2025 was $4.1 million, or $0.02 per share, compared with a net loss of ($3.5) million, or ($0.03) per share, for the Third Quarter ...

With the rise of Industry 4.0 and smart manufacturing, industrial display monitors are no longer optional—they are a key ...

A number of local veterans and their families gathered on the blustery, cold morning of Tuesday, Nov. 11, 2025, at the ...

Many global companies, including retailer Walmart, are continuing their climate policies, but often doing so quietly to avoid ...